TorreyPines Therapeutics Initiates Clinical Trial To Evalua

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Clinical Trials News
Reply to topic
TorreyPines Therapeutics Initiates Clinical Trial To Evalua
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Thu Jun 05, 2008 8:22 am Reply with quote
TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced it has initiated a clinical trial to evaluate the analgesic effect of NGX426, the oral prodrug of its lead product candidate, tezampanel. The randomized, double-blind, placebo-controlled Phase I trial will enroll 18 healthy volunteers at a single center in the United States.

Read more...
View user's profileSend private message
TorreyPines Therapeutics Initiates Clinical Trial To Evalua
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Clinical Trials News
 Reply to topic  
Forum Map
Site Map